Topics

FDA OKs new indication for Janssen's Invokana in type 2 diabetes

05:11 EDT 1 Oct 2019 | SmartBrief

Janssen's Invokana, or canagliflozin, gained FDA approval for a new indication covering use of the drug to decrease the risk  -More

Original Article: FDA OKs new indication for Janssen's Invokana in type 2 diabetes

NEXT ARTICLE

More From BioPortfolio on "FDA OKs new indication for Janssen's Invokana in type 2 diabetes"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...